Plain-English translation of NCT06276374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study tests whether patients at high risk of bleeding do better with one blood-thinning medication (aspirin or clopidogrel) or two blood-thinning medications (aspirin and clopidogrel combined) after having a stent placed in their carotid artery—the major blood vessel in the neck that supplies blood to the brain. Everyone starts with both medications for one month after the stent, and then half the participants continue with just one medication while the other half continue with both for the next 11 months. The goal is to find the safest approach that still prevents strokes.
After carotid artery stent placement, patients typically take two blood-thinning medications to prevent blood clots and strokes, but for people at high risk of bleeding, this double therapy increases the chance of serious bleeding. Researchers want to find out whether one medication alone might provide good protection against stroke while reducing dangerous bleeding in these high-risk patients.
You likely qualify if…
You likely don't qualify if…
After your carotid stent placement, you will take both blood-thinning medications together for one month. Then you will be randomly assigned to either continue with one medication alone or keep taking both medications for the next 11 months. You will visit the clinic at 5 months and 11 months after randomization to check on your progress, and then have yearly follow-up visits or phone calls through December 2029 to watch for any long-term effects. The study tracks whether you experience any strokes, heart attacks, or serious bleeding events.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
South Korea